182 related articles for article (PubMed ID: 21703011)
1. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
[TBL] [Abstract][Full Text] [Related]
2. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
Neo JH; Ager EI; Angus PW; Zhu J; Herath CB; Christophi C
BMC Cancer; 2010 Apr; 10():134. PubMed ID: 20380732
[TBL] [Abstract][Full Text] [Related]
3. The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
Wen SW; Ager EI; Neo J; Christophi C
Cancer Biol Ther; 2013 Aug; 14(8):720-7. PubMed ID: 23792575
[TBL] [Abstract][Full Text] [Related]
4. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
[TBL] [Abstract][Full Text] [Related]
5. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.
Neo JH; Malcontenti-Wilson C; Muralidharan V; Christophi C
J Gastroenterol Hepatol; 2007 Apr; 22(4):577-84. PubMed ID: 17376054
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
7. Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system.
Nguyen L; Ager EI; Neo J; Christophi C
J Gastroenterol Hepatol; 2016 Oct; 31(10):1773-1782. PubMed ID: 26849969
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
Anandanadesan R; Gong Q; Chipitsyna G; Witkiewicz A; Yeo CJ; Arafat HA
J Gastrointest Surg; 2008 Jan; 12(1):57-66. PubMed ID: 18026817
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
[TBL] [Abstract][Full Text] [Related]
10. Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?
Hollenberg NK; Fisher ND; Nussberger J; Moukarbel GV; Barkoudah E; Danser AH
J Hypertens; 2011 Dec; 29(12):2454-61. PubMed ID: 22002336
[TBL] [Abstract][Full Text] [Related]
11. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
[TBL] [Abstract][Full Text] [Related]
12. Role of ACE/AT2R complex in the control of mesenteric resistance artery contraction induced by ACE/AT1R complex activation in response to Ang I.
Su J; Palen DI; Boulares H; Matrougui K
Mol Cell Biochem; 2008 Apr; 311(1-2):1-7. PubMed ID: 18084722
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
Kusunoki H; Taniyama Y; Rakugi H; Morishita R
J Am Heart Assoc; 2013 Apr; 2(2):e000103. PubMed ID: 23608606
[TBL] [Abstract][Full Text] [Related]
14. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
Liu E; Xu Z; Li J; Yang S; Yang W; Li G
Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders.
Maeda A; Tamura K; Wakui H; Ohsawa M; Azushima K; Uneda K; Kobayashi R; Tsurumi-Ikeya Y; Kanaoka T; Dejima T; Ohki K; Haku S; Yamashita A; Umemura S
Int J Med Sci; 2014; 11(6):646-51. PubMed ID: 24834011
[TBL] [Abstract][Full Text] [Related]
16. Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2⁻/⁻ mice.
Bridle KR; Sobbe AL; de Guzman CE; Santrampurwala N; Jaskowski LA; Clouston AD; Campbell CM; Nathan Subramaniam V; Crawford DH
Liver Int; 2015 Apr; 35(4):1451-63. PubMed ID: 24517519
[TBL] [Abstract][Full Text] [Related]
17. Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
Higuchi T; Fukushima K; Xia J; Mathews WB; Lautamäki R; Bravo PE; Javadi MS; Dannals RF; Szabo Z; Bengel FM
J Nucl Med; 2010 Dec; 51(12):1956-61. PubMed ID: 21078800
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
19. Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer.
Herr D; Rodewald M; Fraser HM; Hack G; Konrad R; Kreienberg R; Wulff C
Gynecol Oncol; 2008 Jun; 109(3):418-25. PubMed ID: 18395779
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen AC; Lind L; Kahan T
Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
